Fibromyalgia & musculoskeletal pain

Association of catechol-O-methyltransferase Val158Met polymorphism with fibromyalgia risk and FIQ scores: an updated meta-analysis

Clin Exp RheumatolPublished Systematic review and meta-analysis

Pooled result · FM risk, COMT Met allele (all study subjects)Result — go to the resultOdds ratio 1.375 95% CI 1.076–1.757

Authors' conclusion

This meta-analysis indicates significant associations of COMT Val158Met polymorphism with both FM risk and FIQ score in FM patients.

Study context

Population
Patients with fibromyalgia (FM) and controls in studies of catechol-O-methyltransferase (COMT) Val158Met polymorphism (Medline, Embase, Web of Science)16 studies
Participants
2,115 vs 1,867
Comparison
COMT Met allele vs Val allele; Met/Met vs Val/Val and Val/Met genotypes
  • FMn = 2,115
  • Controlsn = 1,867reference
Outcome
Association of COMT Val158Met polymorphism with FM risk and FIQ score
Methodological detailsupdated meta-analysis, regional stratification, recessive, dominant and homozygote contrast models
  • Updated meta-analysis
  • Regional stratification
  • Recessive, dominant and homozygote contrast models

Pooled result

FM risk, COMT Met allele (all study subjects)

Odds ratio

1.375

95% CI 1.076–1.757

P = 0.001

COMT Met allele
OR 1.375 (95% CI 1.076–1.757); P = 0.001

As reported in the abstract

Further pooled results

OutcomeWMD (95% CI)P value
FIQ score by COMT genotype (8 studies, 1,199 FM patients)Met/Metvs Val/Val11.24 (4.742–17.74)P = 0.001
FIQ score by COMT genotype (8 studies, 1,199 FM patients)Met/Metvs Val/Met5.950 (2.017–9.893)P = 0.003

FM risk, COMT Met allele, by region (European, Latin American, Asian)

No association in European, Latin American, or Asian populations; same pattern with recessive, dominant and homozygote contrast models

Original publication

Association of catechol-O-methyltransferase Val158Met polymorphism with fibromyalgia risk and FIQ scores: an updated meta-analysis. Clin Exp Rheumatol. Published 28 September 2024. doi:10.55563/clinexprheumatol/8njnoh

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.